N
Google TrendANNA BONDAR (200+) — October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Targeting GLP-1 receptor" (30 stories)

Top Headline Story

Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial
Lead StoryNaturegeneral
Aug 14

Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE84WGN2b04tdUNZdkw4Vmx4Y1phcHFwczNXdFZNVXRwN3Y1X25BZTlhTWw4RGVoOEFpNUNQbWtFNG0xdjhneXZOR1pseHhPdThtektSdG9jUmZxZjlTMS04?oc=5" target="_blank">Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+18m ago

anna bondar

October 12, 2026: Tommy Paul vs Valentin Vacherot: Set 2 Winner Tennis Prediction Market

Filter stories
100+18m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+28m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+28m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "Targeting GLP-1 receptor"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets
Psychiatrist.comgeneral

Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQREFoYnVqVi00Q01zX0NyRFh0S2h5UUhZV0dzaFRILTI2SWJUOU5aM0ZCM2ZrRkR4U0hMOXN1N2pFaTl6YkEyUVR0T1Z5ZFlfX1hjbGsxXzhiakhNMGJfMlpTbS1fUy00VGktU3pZWVoyd09GNzg3RU9aT2E2OHZtdER2VlFCRzdmRG9QS1NEaTV3cGtlenZXRDBxdFdKRW9UUnB1U2dlS25HWFFScVlQY2xCVTVORTY5aEQwVzV6VURvLURFRzlvSzZR?oc=5" target="_blank">Prescribing GLP-1 Receptor Agonists for Persons With Mental Disorders: Evidence-Based and Aspirational Targets</a>  <font color="#6f6f6f">Psychiatrist.com</font>

Read Full StoryMore like this
Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation
Frontiersgeneral

Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQMHM1N3VvRnZfRG9rSjlGZkh5TnhXVldYS1g1TzRHYU5PTVJHYUllUEF3NkNBaEo0S3N2aWgyN1lYTl9HSEVvemtnNkp5X3pzbXZhU1pyRUN5VG8xRHJ2X2Q0Q2UwS1V5M3Y1LWk5X2JvSTdqNFRDTFpwelNDUy1sNzlTYW5nd3VmbW84Slg2bW1UMHNSblo3ZTM4ckxLZFlO?oc=5" target="_blank">Suicidality as a potential risk and therapeutic target during widespread GLP-1 receptor agonists use: implications of inflammation</a>  <font color="#6f6f6f">Frontiers</font>

Read Full StoryMore like this
GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression
Targeted Oncologygeneral

GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPeHdiNWdNTUlMOW9faTBxOGtaYzNSVVhYdVpQRUhjUUZidmUyM3JjT01SdGMzUm9MTldQYnZqTFdrVkhSZVo0dndnRHNiMmpYLTNFdHRzOTdFbjIxeFQ2Y0ZFdzBjRWNkZ2NRVnduZng4aU1KbHg2NEJKc3djcTFVc0t0QzdaeFNSME9GSGNwSHA3YlgzN0FyUk9sZ09Kakd4NV9kdHgtV2VhLXJlWnFaMjBn?oc=5" target="_blank">GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
STATgeneral

Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target

<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE1rQ2o1VGdnbWhZcUdIUDQzeGdRWThLakw1d2JvWTFnam5TeGtySTI5TTV2ajV6SjU3ZUg4eF9Bb05xYnRXUUNjTHB2M2xjOHBCTklldTN6M252dmJIcFVLR0s0ZkdVdlBHeF9lSFZCM1ctV0pI?oc=5" target="_blank">Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
Why addiction researchers are paying closer attention to GLP-1 drugs
News-Medicalgeneral

Why addiction researchers are paying closer attention to GLP-1 drugs

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPN2VoVTVYWUpseGFVaGFoTWhtUWNHVzVPc0xQYzBXWHF3eFJrdTI5d2xDVzlOeFJianB6MzVIZjJSdGM0czBHUlo4azdlUDFZanBKcU9KLUlGQmIwcDN5bWQxeXhzTFB6bXJCczhDU2k5SU1tcERYYWF5N3dlb19LeWVPUlFzYThxeVdfUFZDemRRS1hZRnRRVnFXeHZBaHBsYVJZYTRmdDhwU0JSWkd2blI4RG9Va2c?oc=5" target="_blank">Why addiction researchers are paying closer attention to GLP-1 drugs</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
eli lillys new weight loss drug
www.polskieradio.plgeneral

eli lillys new weight loss drug

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNeXFkSkhlaXQwUlBDNHlyakFCVHpmZE5TQnhBVl9yTXZMM2syQWZZSHpLSWM3dmtBcVR6MlZEZnFIODk3ckRRdExTWUFqdGhPYnpkRThIZkN5YmZoR2ktU0lTUkxRQzE4TTYxeURvMkUtdjFMQld2U09BYV9RdlFidjc0TFU5OThy?oc=5" target="_blank">eli lillys new weight loss drug</a>  <font color="#6f6f6f">www.polskieradio.pl</font>

Read Full StoryMore like this
Beyond A1c Is Not Enough: How GLP-1 Therapy Is Changing Frontline Care
Physician's Weeklygeneral

Beyond A1c Is Not Enough: How GLP-1 Therapy Is Changing Frontline Care

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxObkpRRWpOZTBjRzRvZzdGZjRUUmRSZWlldXhyZFRwX0Y5TVpjQXc0WVJGcThwSFdKNXFJZGdUTUpqNThJU3J4UVRDVHZjZk5UUEZhb2JVdmE5eDBZd3pGVzNGTENnT05lMk1iY3VFTHVnZjlHZVYxcEVkVmNYU29Dd0JTNjFSWFpIM1R6cjI1RnIzUGNEMXd6Q3hrakRGRXNhUzI1ZDEya080eURUOHc?oc=5" target="_blank">Beyond A1c Is Not Enough: How GLP-1 Therapy Is Changing Frontline Care</a>  <font color="#6f6f6f">Physician's Weekly</font>

Read Full StoryMore like this
Understanding GLP-1 receptor agonists and their impact on drug discovery
Drug Discovery Newsworld

Understanding GLP-1 receptor agonists and their impact on drug discovery

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQbkgtYjJqeHRhQTh2aHlkX2d1TGVqZGFXdjFrTDJxRDdubGc3dUVIVTZiM2JFMnFuY3I4c2duTzRHSHlhZ3p3T2JwVG1GMThiMVNRTW9lbkIzQmsxV0VSMmJPYkNsLXQtdTY0ZUVrQm01cHFFY0FBNDJMT2VRVG1QY1oxSXRhbVVsdUtUVVo4ZWV5em9RQnk4NlJSTEFnQnlmQlJrNXVwVUdlWnBYTExQQUlB?oc=5" target="_blank">Understanding GLP-1 receptor agonists and their impact on drug discovery</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
Weight loss research questions need for GLP-1 drugs
Medical Xpressgeneral

Weight loss research questions need for GLP-1 drugs

<a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1VaF9QT25RNGlWYWM2T1VUcm9HSXV6cE4wSG91YWl0S3dNUW9hZllKdGFTT0NYSms4U0FOb1ZsbndUZHVHYXY3b0R3ZzBMWGFZSnktTkJVVGJqMzMtdlBUN2VPVzJsaFR2TlhCb3hhMDcxdHM?oc=5" target="_blank">Weight loss research questions need for GLP-1 drugs</a>  <font color="#6f6f6f">Medical Xpress</font>

Read Full StoryMore like this
Not just GLP-1: Peptide-drug conjugate hits 5 obesity targets
Chemical & Engineering Newsgeneral

Not just GLP-1: Peptide-drug conjugate hits 5 obesity targets

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxOZEF2UVI5OEx3VnA4MzZ5U1hia29ueU16WEthZmFDSEgxcXg5RWFsaTVzNGF0ZE5ZSGw1NHF6NGFsM0ZDUXkxMWd3UGl2TnQ5MXhBbUpKeUxublNBcTljZGtvUjhUWERtWGp0UnZ6b1ZHN0R0c3RDdGY2Mmp1UXB0elREMEJIcWFITjJiV0VsUTZWbGxiVUwwcVMzX1FuemhuNUpzZDJVaW9MRDBmcWE2c0pfNjJUQQ?oc=5" target="_blank">Not just GLP-1: Peptide-drug conjugate hits 5 obesity targets</a>  <font color="#6f6f6f">Chemical & Engineering News</font>

Read Full StoryMore like this
The GLP-1 revolution: What UAB researchers are discovering about how these drugs work | UAB News
The University of Alabama at Birminghamgeneral

The GLP-1 revolution: What UAB researchers are discovering about how these drugs work | UAB News

<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxNbzd6b2xoanVhRDNqRzB4WkUtcTFMdXdBUE1fTmUyVTNnSG1BOWhiLVMzVVE3TndFWDktNC1tcVZMc1laRmVMRzYyVW9NUXpPb05vN3FOUGVPSks3MzhaTW1yYlpXYkk5VDVyOE9rQnJCLVk4VnAxeXRmYldIXy1LcnpNZjE4aEJCQ2U5b2FjZ05KQ0x1eUdRekVpcmVULS1idXBTTmxLamlRZlB0cW03emRxOWdreUxnZUxCWGJCX0taeEE3VENzUw?oc=5" target="_blank">The GLP-1 revolution: What UAB researchers are discovering about how these drugs work | UAB News</a>  <font color="#6f6f6f">The University of Alabama at Birmingham</font>

Read Full StoryMore like this
Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial
Naturegeneral

Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE04dng2MzlReXQtUXpoTnBqeHZEUkpSSE1VaGRvN3ZzMXZtTFF2RFFGMUs2VFhESUhLNWRicmUyT245ZFNNSlFjb1pnNmZBb3NTM3JWTDkwQXMxRjNkZWNj?oc=5" target="_blank">Bispecific GLP-1/GLP-2 agonism in advanced type 2 diabetes: preclinical characterization and a randomized, double-blind, placebo-controlled phase I trial</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
GLP-1 Targeting Can Induce Terminal Differentiation in Liposarcoma
Targeted Oncologygeneral

GLP-1 Targeting Can Induce Terminal Differentiation in Liposarcoma

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNVVVTX1JvQkgxZ3ZJUWVjMFlFcHJXRTV2cmpwYS0yVDI5SFFGSFdVLVk4TkgzOVJwbElUR2t2azNGTzJlSC1kcm5EUUJzWk9KTnFPdXVVZlk0NC1HM2hNaGhmZ3FCLVEtVHVJdmpiUnlSMGJsV05iYmhseGZodGZOdHpYWXdwVDZZdmhRdWxWVkxJMkRtNDNvUjc0WDlXX01F?oc=5" target="_blank">GLP-1 Targeting Can Induce Terminal Differentiation in Liposarcoma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
tirzeparide
www.polskieradio.plgeneral

tirzeparide

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE1kY0MxbUpiUVVNaGpvdUZUcVhXai02VmRzb0FKemJRUXpFWHNLR0JDSEhKenRsR3czdW9lUENLeGJKaWpYZ1ZsdlFlODJTMERGN1JvNUhxZS00YW1QTnY0QlFhdzFvSkw3R0E?oc=5" target="_blank">tirzeparide</a>  <font color="#6f6f6f">www.polskieradio.pl</font>

Read Full StoryMore like this
DataMeds AI launches health app targeting GLP-1 users
Investing.comtech

DataMeds AI launches health app targeting GLP-1 users

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPcS1KYmducWlpbEZUTTM4X0ppbFFsQjd6NnNzZEdMUUd6RVNRXzA2TmJvUzdmSUppaThLLXhyUm8wcmJ0Z1p3cEVjYXdKXzBOc3RHV2JoMVZHcUFIRTdWcDNlNU50LXB0YUFQN01vbnRnOGQzMmc1RDJUOVhxZUVObEp2N0s2QXF2OTQzR1VnVVV4My1MVTkzOUJnSGV3WHV2T1phQXpXeFZIaTdOTXc?oc=5" target="_blank">DataMeds AI launches health app targeting GLP-1 users</a>  <font color="#6f6f6f">Investing.com</font>

Read Full StoryMore like this
GLP-1 drugs may help curb addiction by targeting reward pathways
News-Medicalgeneral

GLP-1 drugs may help curb addiction by targeting reward pathways

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPdWJ0QmpEcnI3blRkWUY4S3Nma2VmLVN5am5VZTB3MDhIekV6RTlHVWxrS0VvbXZSZ3kyV0ZkSzlQekp1cUJEY2JsenJ6eS1oa2FKb0N5SjRTQ0NkWk5kNjZDYndsLTM1VkpkbWthVXQ4d1RnSVhlTzV5Z0dyZlAwX3ozT1lfWmhtdFYtRnktWVV2RlBvSlhXb1k0Y3pKVEJMb0R4MU5HNGJ0M0c5U2ZPcFdB?oc=5" target="_blank">GLP-1 drugs may help curb addiction by targeting reward pathways</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
PrecisionLife and Ovation Target GLP-1 Response Variability with New Biomarker-Driven Collaboration
BioPharm Internationalgeneral

PrecisionLife and Ovation Target GLP-1 Response Variability with New Biomarker-Driven Collaboration

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxNWkZSU2dKMlRLOHFrUG1hTXpMMnRzRTVjWDBMcGFVSUdHODlfWTNQOHRBcWNkSGFkWE5qRlRGR2VGd1ZiaFNhakZId2U1TDdQUzNCci1yTG9UMkVZRW9kV2tCRzlNRUdETHpzNEhzcUtpaFI2eEc4Zk93eEZsOFZ6Q3JMeWYxOC10eXpoYUVBZGt3LTFFam5BamFtRkZmNDE5Ql9UMFQ1cXl2TDRaeUw2WjE0QXZKb1JWb0t4a01RbmlzbFFxTHo4UzlyVzZGRGprSU4zbDdhNUhDdw?oc=5" target="_blank">PrecisionLife and Ovation Target GLP-1 Response Variability with New Biomarker-Driven Collaboration</a>  <font color="#6f6f6f">BioPharm International</font>

Read Full StoryMore like this
GLP-1s Taking Over Indications Outside of Diabetes and Weight-Loss | APhA 2026
Drug Topicsgeneral

GLP-1s Taking Over Indications Outside of Diabetes and Weight-Loss | APhA 2026

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNc01acWFLMjlzdVVHUzdYNUpyQTc1TU9mRzNqV3VJeWU2STMzWWZsc2w2cGdXYVZIa3N4MDBsTF9YS0tESWJMb2hKQVY4bEdrYi1TVmVveWtFRDVaX29RUWVxdnZucWFqUjJGOFlXNDIzcVEzZ0N6YzBXZS1QbFhpTU8xYVdhRkFiSmJydWlmZEJBMTdWLW4wMnYyM2xPMGp5clZ6OUN2LWd2dHdt?oc=5" target="_blank">GLP-1s Taking Over Indications Outside of Diabetes and Weight-Loss | APhA 2026</a>  <font color="#6f6f6f">Drug Topics</font>

Read Full StoryMore like this
The GLP-1 Revolution
Yale School of Medicinegeneral

The GLP-1 Revolution

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQZ0Q4MmVRTEw4R0FpVVVtc2lLU3NUQlJMYUt3dmk5UzIzZVlfQXVyZFk1enFVQTZSSEEwUWs5VWZWeXF3QjN2QlU0ZXVlMHI2bDdBNzlNcml5Z0tNRHg0TmRLWTVkeDBuMVRJUTlhSVpKLW8yTjg0aGxpa1lXeVdjTDB4NGo?oc=5" target="_blank">The GLP-1 Revolution</a>  <font color="#6f6f6f">Yale School of Medicine</font>

Read Full StoryMore like this
Five-target drug beats GLP-1/GIP therapy in obese diabetic mice
News-Medicalgeneral

Five-target drug beats GLP-1/GIP therapy in obese diabetic mice

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQRE5tREZQZEh2VEpEem9KSlVmWnNKM28tSHZXOEN5U29Tc1MyVkhiYnZzM1VnelZpTjZqMVJjREhWRnNIOXljdTBPZHFXZWVrdWlIQ29Cbm1OeUJXN29xd1V6TTZDRmg5NnNQS29jcnlfZ3lUcXA3cHNJaWdpdXhDQ29CTU9pMGZUamhlTUh5SWRXQjNoaFNGMmdZaUhfRFhiNTcxMEVzc0w3Q1RadnAw?oc=5" target="_blank">Five-target drug beats GLP-1/GIP therapy in obese diabetic mice</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
Can amylin weight-loss drugs compete in a world of GLP-1s?
Chemical & Engineering Newsworld

Can amylin weight-loss drugs compete in a world of GLP-1s?

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxNNnlDdGJHdXFGRHEybDJWSXN6VGM2d1JHd1dVSkZWX1lOd2dpa3dIZlJLV0lOeHh5d3VmQWtWeTJjSFFTMVY0TFVtMXNNMTM2aHc0Rm5wM1lfNG1lUVJXZXllVlI2bmdVWW51ZFBZbC01RG5nX294dVYtb2JhVktFYmdPX0dyT0xEb0hOeQ?oc=5" target="_blank">Can amylin weight-loss drugs compete in a world of GLP-1s?</a>  <font color="#6f6f6f">Chemical & Engineering News</font>

Read Full StoryMore like this
What Are Meds Similar to Mounjaro?
polskieradio.plworld

What Are Meds Similar to Mounjaro?

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTFBCeTljOW9FcGdpQTFMQjEyeEtGblhmZUFRQUlISUJtTU5HWFRLNGY0M2NPcy1uTEdrTm5MRDhTUTBMN1ZYVzBETGowTmVwd1kzdEpBbVE2NWNZNWRmS1hXZDFGWmNVbTlyZXZlTkgzSl9qcFVJelRIR1dFcw?oc=5" target="_blank">What Are Meds Similar to Mounjaro?</a>  <font color="#6f6f6f">polskieradio.pl</font>

Read Full StoryMore like this
NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets
GlobeNewswiremarkets

NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets

<a href="https://news.google.com/rss/articles/CBMivwJBVV95cUxNU09KZHRtc3lwVHVkVENKZTA5YUFrNExZeFFHN2U4Xzh2elBPNDl2a25WOWlwdXNVRy0tVkxXQW1ad2xQOUZhSGlDbjF1WTJSYmlwSmJsbnBIS052UDc4bkppWkprYVpCeTNpMnNHOG5oNnNJVWNubWgzTWE5cW00U1RMX19mcXVFRjZIN1FkUUM3N2kwNElTd3VLMF9scmV4LWxRRDNYUjFxak03MmpSeWl6anYxT0dKOVpBRkFVbGJvSmY2RFlIcENmM00wZkstbmRaNDdWMXNPQXB5c29MXzlWQVFPWjExZVZqRFFaOG44R0xudU0xVmZNaTQwRHVRaTJXaHlwOFdpblhtZmU0cFU5SGVvMGRnZ1hzMlNwSHRmazZjUkZ0Um1IY3VWaTJLM2pPUm5nVE10eVJpZi00?oc=5" target="_blank">NorthStrive Biosciences Files Two New U.S. Patent Applications Targeting Muscle Preservation in GLP-1 and Next-Generation Obesity Treatment Markets</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Intriguing New Targets – Including GLP-1 – in Liposarcoma
Dana-Farber Cancer Institutegeneral

Intriguing New Targets – Including GLP-1 – in Liposarcoma

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNZU5scTNFaUU4VlpEaEpUZ2lKbmRoVjNmeHhTSl83Vk0yUGdRQUk4U0ZBOWVFelFJUjJNN1RhMVdzc3VZMFpCZHVWQjRlSEtDeWdWLXJGYUZwbnhtYWZmTnc2bTlIN1JPQmhPVlBXcUZHQzZFNXlfcW85eTg3SU94cQ?oc=5" target="_blank">Intriguing New Targets – Including GLP-1 – in Liposarcoma</a>  <font color="#6f6f6f">Dana-Farber Cancer Institute</font>

Read Full StoryMore like this
ADA 2026: Obesity Pharmacotherapy and the Future of Weight Management
Pharmacy Timesgeneral

ADA 2026: Obesity Pharmacotherapy and the Future of Weight Management

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxPY0pPV05QRW1fQ1NFVU5ZbEVMVWNCMWJxd2RPeWZkcDhiQVVqZVdxbGRySGRROE51MnVLTnNmRVZEcTRMMENuSjRrRHU4ZTFMQzZjSHB6cF9BbElxNTc1Uk5BemJOZVhCTk4xcFhFaUR4dWM0LWg4TEJZQUthTEszMmpHY2xwSE11ZGNra0FTMG5OdG95N01GRmZ2MXA0VGY5bXJKb3VB?oc=5" target="_blank">ADA 2026: Obesity Pharmacotherapy and the Future of Weight Management</a>  <font color="#6f6f6f">Pharmacy Times</font>

Read Full StoryMore like this
Are peptide drugs the only answer to the hundred-billion-level weight loss market?
News-Medicalmarkets

Are peptide drugs the only answer to the hundred-billion-level weight loss market?

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQRjdSV2RvTlRHbGVzZF84RWJHbGZiRWJ3dDFnSVFFYXRUMENIZHNiY05Rako4eEg3T3dpREUzQjhtbnRvc2t5TFgwcFNzbGdDOUZ0MGRibF9mV1VpVlQ4Nk5BYTlfSGxXS0pCc2xLeE9BYWQxY2xHOTctZ2xKM2w5WkFCeW8xM0l1cnY3OTktU0I3SUxiUGNYRjUzT0NRTHhoenpsZXpVeHpqdFJCY2ppaUF3azc5V2VCbzF0OFRkb2k3U2xzU2JRbHVka0ZnRURI?oc=5" target="_blank">Are peptide drugs the only answer to the hundred-billion-level weight loss market?</a>  <font color="#6f6f6f">News-Medical</font>

Read Full StoryMore like this
GLP-1 Drugs Target the Roots of Dementia
Neuroscience Newsgeneral

GLP-1 Drugs Target the Roots of Dementia

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9QS2VIdF93T2xDZmY0WExHblhTSm9EVjZoVkw1MmpRT1lXdjhQV1VpOGZtdkpuUF80aGo5X1pxeDY3QlZNLXMybUIyUmRna05NTjF6REtTMllUc3NDVm5VNjAtZ2Qydk5yYWpGSVJ1UFJUSGdxSmdQa2x3?oc=5" target="_blank">GLP-1 Drugs Target the Roots of Dementia</a>  <font color="#6f6f6f">Neuroscience News</font>

Read Full StoryMore like this
fda approved weight loss drugs 2026 tirzepatide semaglutide retatrutide
polskieradio.plgeneral

fda approved weight loss drugs 2026 tirzepatide semaglutide retatrutide

<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBjb05kck5qeGk2MFBMZWllUDlLcldDNHRUSlpBRG05Z2ZtUEhiODlzY1JfRTBqM19Odmc0M1E5QkVjOVFQM3FYOGZ6bjVPaTdsV3dXN2E5eEJyeHhxM25RTDdGX0tXQzNwenNwa1ZzamQ?oc=5" target="_blank">fda approved weight loss drugs 2026 tirzepatide semaglutide retatrutide</a>  <font color="#6f6f6f">polskieradio.pl</font>

Read Full StoryMore like this
An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different.
Health.comgeneral

An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different.

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQOUVaUXJnTWtrdW9LN21uMHJ3TGJuUV9hT24tZDlvMWxLbVptdWdQWVVNQWdVOHdMVWFDcGNpYTdDeE5zcEtPanFmd3BqMlpGdmlPdHI4WHhnenBOR1pnUmozNmdVeWFfSjhvbmFYcjRUN1l2bTNCejFxZWIzalI1SlZ3?oc=5" target="_blank">An Experimental Weight Loss Drug Could Outperform Ozempic. Here’s What Makes It Different.</a>  <font color="#6f6f6f">Health.com</font>

Read Full StoryMore like this
"Targeting GLP-1 receptor" — Live Google News Trends & Headlines